Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

22
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.4K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.3K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Atypical Pneumonia01:14

Atypical Pneumonia

80
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
80
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.6K
The pathophysiology of pneumonia involves the following steps:
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexually Transmitted Infections in Pregnant Women: Integrating Screening and Treatment into Prenatal Care.

Paediatric drugs·2018
Same author

Genomic Epidemiology of Methicillin-Resistant Staphylococcus aureus in a Neonatal Intensive Care Unit.

PloS one·2016
Same author

Salmonella Infections in Childhood.

Advances in pediatrics·2015
Same author

Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

Pediatrics·2014
Same author

Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit.

American journal of infection control·2011
Same author

Pediatric outpatient parenteral antimicrobial therapy: an update.

Advances in pediatrics·2010

Related Experiment Video

Updated: Apr 27, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K

Pneumococcal infections.

Nizar F Maraqa1

  • 1Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, University of Florida College of Medicine, Jacksonville, FL.

Pediatrics in Review
|July 3, 2014
PubMed
Summary

The pneumococcal conjugate vaccine lessens disease burden but impacts nonvaccine serotypes and resistant strains. For uncomplicated infections, narrow-spectrum antibiotics like amoxicillin are recommended, while severe cases require parenteral agents based on susceptibility.

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Antimicrobial Resistance

Background:

  • Observational studies show pneumococcal conjugate vaccines reduce disease burden.
  • Vaccine use influences the epidemiology of nonvaccine serotypes and antibiotic-resistant *Streptococcus pneumoniae*.

Purpose of the Study:

  • To review evidence on the impact of pneumococcal conjugate vaccines on disease epidemiology.
  • To provide guidance on appropriate antimicrobial treatment for pneumococcal infections.

Main Methods:

  • Analysis of observational study evidence.
  • Synthesis of data on antimicrobial susceptibility patterns.

Main Results:

  • Pneumococcal conjugate vaccines have significantly reduced overall pneumococcal disease.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.9K
Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

17.5K

Related Experiment Videos

Last Updated: Apr 27, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.9K
Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

17.5K
  • There is an observed shift towards nonvaccine serotypes and increased prevalence of antibiotic resistance.
  • Amoxicillin is effective for uncomplicated infections caused by susceptible strains.
  • Parenteral antibiotics guided by susceptibility testing are crucial for severe or resistant infections.

    • Conclusions:

    • Continued surveillance of pneumococcal epidemiology is essential.
    • Antimicrobial stewardship is vital, with narrow-spectrum agents preferred for susceptible infections.
    • Treatment decisions for severe or resistant pneumococcal infections must be individualized based on pathogen susceptibility and infection site.